Stem Cell Therapy for Spinal Cord Injury
Keywords: Adult stem cells; Allodynia; Bromodeoxy-Uridine; Bromodeoxyuridine; Epidermal growth factor (EGF); Gadolinium-diethylene triamine peta-acetic acid (Gd-DPTA); Glial-derived nerotrophic factor; Neurotrophin-3; Peripheral nerve graft; Schwann cells; Spinal cord injury (SCI); Sry-related HMG box 2; Subgranular zone; Subventricular zone; Tumourigenicity; Von Hippel-Lindau protein; aminopyridine; astrocytosis; blastomeres; blood-spinal cord barrier (BSCB); cerulospinal axons; chondroitinase ABC; ciliary neurotrophic factor; corticosteroids; diffusion tensor imaging (DTI); embryonic stem cells; embryonic stem cells (ESCs); ependyma; excitotoxicity; fibroblast growth factor-2; fibroblasts; hippocampal; hodgepodge; iPS cells; induced pluripotent stem cells; insulin growth factor-1; mesenchymal; mesenchymal stem cells; mesylate; metalloproteinases; methylprednisolone; motor neurons; myelination; naloxone; neurogenesis; neuroprotective agents; neurotrophins; noxious stimuli; olfactory ensheathing cell (OECs); oligodendrocyte; oligodendrocytes; pluripotent cells; pluripotent stem cell; spasticity; spinal cord; spinal cord injury; stem cell therapy; stem cell therapy (SCT); superparamagnetic iron oxide (SPIO); synergistic effects; teratoma; tirilazad; tizanidine; tumour necrosis; umbilical cord blood (UCB); vascular endothelial growth factor (VEGF)
Document Type: Research Article
Publication date: 2010-12-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.